Implitapide Racemate
98%
- Product Code: 108597
CAS:
177277-99-5
| Molecular Weight: | 531.69 g./mol | Molecular Formula: | C₃₅H₃₇N₃O₂ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C, airtight, dry |
Product Description:
Implitapide racemate is primarily utilized in the field of medical research, particularly in the study of lipid metabolism and related disorders. It serves as a potent inhibitor of microsomal triglyceride transfer protein (MTP), making it a valuable tool for investigating conditions such as hyperlipidemia and atherosclerosis. Researchers employ Implitapide racemate to better understand the mechanisms underlying lipid absorption and transport, which can lead to the development of novel therapeutic strategies for managing cardiovascular diseases. Additionally, its role in reducing plasma cholesterol and triglyceride levels has been explored in preclinical studies, highlighting its potential as a candidate for lipid-lowering therapies. However, its use is currently limited to experimental settings, as further studies are required to assess its safety and efficacy in clinical applications.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.001 | 10-20 days | $5,422.03 |
+
-
|
Implitapide Racemate
Implitapide racemate is primarily utilized in the field of medical research, particularly in the study of lipid metabolism and related disorders. It serves as a potent inhibitor of microsomal triglyceride transfer protein (MTP), making it a valuable tool for investigating conditions such as hyperlipidemia and atherosclerosis. Researchers employ Implitapide racemate to better understand the mechanisms underlying lipid absorption and transport, which can lead to the development of novel therapeutic strategies for managing cardiovascular diseases. Additionally, its role in reducing plasma cholesterol and triglyceride levels has been explored in preclinical studies, highlighting its potential as a candidate for lipid-lowering therapies. However, its use is currently limited to experimental settings, as further studies are required to assess its safety and efficacy in clinical applications.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :